Alkem Laboratories Limited
ALKEM
Classifica tra le azioni
#2816
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Prezzo delle azioni
$55.19
Capitalizzazione di mercato
$6.60B
Variazione (1 giorno)
-0.06%
Variazione (1 anno)
-12.43%
Paese
IN
Scambia Alkem Laboratories Limited (ALKEM)
Categoria
Healthcare
Rapporto P/B per Alkem Laboratories Limited (ALKEM)
Rapporto P/B al October 2026 TTM: 4.31
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Alkem Laboratories Limited, il rapporto P/B attuale (TTM) è 4.31. Alla fine del 2024, era pari a 5.81.
Storico del rapporto P/B per Alkem Laboratories Limited da 2010 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 4.31 | -10.49% |
| 2025 | 4.82 | -16.94% |
| 2024 | 5.81 | 29.38% |
| 2023 | 4.49 | -10.43% |
| 2022 | 5.01 | 11.63% |
| 2021 | 4.49 | -0.54% |
| 2020 | 4.51 | 17.52% |
| 2019 | 3.84 | -18.59% |
| 2018 | 4.72 | -20.04% |
| 2017 | 5.90 | 34.33% |
| 2016 | 4.39 | -20.25% |
| 2015 | 5.51 | -11.47% |
| 2014 | 6.22 | -10.59% |
| 2013 | 6.96 | -19.73% |
| 2012 | 8.67 | -25.08% |
| 2011 | 11.57 | -15.57% |
| 2010 | 13.71 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 16.85% |
IN
|
